Le Guellec C - Search Results

1

Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma.

Blasco H, Senecal D, Le Gouge A, Pinard E, Benz-de Bretagne I, Colombat P, Hulot JS, Chatelut E, Le Guellec C. Blasco H, et al. Among authors: le gouge a, le guellec c. Br J Clin Pharmacol. 2010 Sep;70(3):367-75. doi: 10.1111/j.1365-2125.2010.03712.x. Br J Clin Pharmacol. 2010. PMID: 20716237 Free PMC article.

2

Relationship between 5-fluorouracil exposure and outcome in patients receiving continuous venous infusion with or without concomitant radiotherapy.

Beneton M, Chapet S, Blasco H, Giraudeau B, Boisdron-Celle M, Deporte-Fety R, Denis F, Narcisso B, Calais G, Le Guellec C. Beneton M, et al. Among authors: le guellec c. Br J Clin Pharmacol. 2007 Nov;64(5):613-21. doi: 10.1111/j.1365-2125.2007.02951.x. Epub 2007 Jun 19. Br J Clin Pharmacol. 2007. PMID: 17578483 Free PMC article.

3

[The need for a better definition of therapeutic indications of carboxypeptidase in delayed elimination of methotrexate].

Blasco H, Silly S, Tournamille JF, Gyan E, Sénécal D, André V, Colombat P, Le Guellec C. Blasco H, et al. Among authors: le guellec c. Therapie. 2008 Jan-Feb;63(1):19-28. doi: 10.2515/therapie:2008013. Epub 2008 Apr 4. Therapie. 2008. PMID: 18387272 French.

4

Pharmacokinetics of rituximab associated with CHOP chemotherapy in B-cell non-Hodgkin lymphoma.

Blasco H, Chatelut E, de Bretagne IB, Congy-Jolivet N, Le Guellec C. Blasco H, et al. Among authors: le guellec c. Fundam Clin Pharmacol. 2009 Oct;23(5):601-8. doi: 10.1111/j.1472-8206.2009.00714.x. Epub 2009 Jul 29. Fundam Clin Pharmacol. 2009. PMID: 19659797 Clinical Trial.

5

Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance.

Benz-de Bretagne I, Zahr N, Le Gouge A, Hulot JS, Houillier C, Hoang-Xuan K, Gyan E, Lissandre S, Choquet S, Le Guellec C. Benz-de Bretagne I, et al. Among authors: le guellec c. Br J Clin Pharmacol. 2014 Aug;78(2):329-42. doi: 10.1111/bcp.12326. Br J Clin Pharmacol. 2014. PMID: 24433481 Free PMC article. Clinical Trial.

6

Pharmacokinetics of rituximab and its clinical use: thought for the best use?

Cartron G, Blasco H, Paintaud G, Watier H, Le Guellec C. Cartron G, et al. Among authors: le guellec c. Crit Rev Oncol Hematol. 2007 Apr;62(1):43-52. doi: 10.1016/j.critrevonc.2006.09.004. Epub 2007 Feb 6. Crit Rev Oncol Hematol. 2007. PMID: 17287129 Review.

7

[Therapeutic drug monitoring of methotrexate after its administration in high-dose protocols].

Le Guellec C, Blasco H, Benz I, Hulin A; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Le Guellec C, et al. Therapie. 2010 May-Jun;65(3):163-9. doi: 10.2515/therapie/2010016. Epub 2010 Aug 11. Therapie. 2010. PMID: 20699066 Review. French.

8

Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease.

Puisset F, White-Koning M, Kamar N, Huart A, Haberer F, Blasco H, Le Guellec C, Lafont T, Grand A, Rostaing L, Chatelut E, Pourrat J. Puisset F, et al. Among authors: le guellec c. Br J Clin Pharmacol. 2013 Nov;76(5):734-40. doi: 10.1111/bcp.12098. Br J Clin Pharmacol. 2013. PMID: 23432476 Free PMC article. Clinical Trial.

9

A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?

Le Guellec C, Benz-de Bretagne I, Jonville-Bera AP, Tarfaoui N, Andres CR, Gendrot C, Jourdain A. Le Guellec C, et al. J Pediatr Hematol Oncol. 2012 Nov;34(8):e341-3. doi: 10.1097/MPH.0b013e318257a4ae. J Pediatr Hematol Oncol. 2012. PMID: 22627576

10

Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of multidrug resistance protein 2 (MRP2) function in humans.

Respaud R, Benz-de Bretagne I, Blasco H, Hulot JS, Lechat P, Le Guellec C. Respaud R, et al. Among authors: le guellec c. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 15;877(30):3893-8. doi: 10.1016/j.jchromb.2009.09.047. Epub 2009 Oct 8. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19836315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters